-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Neuroendocrine tumors (NETs) are gradually becoming familiar to people.
Neuroendocrine tumors (NETs) are gradually becoming familiar to people.
The study is a population-based retrospective cohort study that included patients with NETs registered in Canada from 2001 to 2015.
The study is a population-based retrospective cohort study that included patients with NETs registered in Canada from 2001 to 2015.
The 5-year risk of tumor-specific death in the overall population of NETs is higher than that of non-tumor-related deaths, with mortality rates of 7.
NETs overall population tumor and non-tumor mortality
NETs overall population tumor and non-tumor mortalityThe tumor-specific mortality rate of patients with primary bronchopulmonary NTEs was the highest.
The tumor-specific mortality rate of patients with primary bronchopulmonary NTEs was the highest.
Tumor-specific and non-tumor deaths in patients with primary bronchopulmonary NTEs
Tumor-specific and non-tumor deaths in patients with primary bronchopulmonary NTEsThe 5-year and 10-year tumor-specific mortality rates of patients with primary pancreatic NETs were 34.
The 5-year and 10-year tumor-specific mortality rates of patients with primary pancreatic NETs were 34.
Tumor-specific and non-tumor deaths in patients with primary pancreatic NTEs
Tumor-specific and non-tumor deaths in patients with primary pancreatic NTEsThe 5-year and 10-year tumor-specific mortality rates of patients with primary colonic NETs were 21.
The 5-year and 10-year tumor-specific mortality rates of patients with primary colonic NETs were 21.
Tumor-specific and non-tumor deaths in patients with gastrointestinal NTEs
Tumor-specific and non-tumor deaths in patients with gastrointestinal NTEsMultivariate analysis found that old age, substance deprivation, and metastasis were associated with a high tumor-specific death risk, while women and concomitant diseases were associated with a lower tumor-specific death risk.
Multivariate analysis found that old age, substance deprivation, and metastasis were associated with a high tumor-specific death risk, while women and concomitant diseases were associated with a lower tumor-specific death risk.
In summary, the overall population of neuroendocrine tumors (NETs) has a higher risk of tumor-specific death than non-tumor-related deaths.
Original source:
Julie Hallet, Calvin Law, Simron Singh, et al.
Julie Hallet, Calvin Law, Simron Singh, et al.
Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis.
J Natl Compr Canc Netw.
2021 Jun 4;1-10.
doi: 10.
6004/jnccn .
2020.
7666.
Online ahead of print.
Leave a message here
